NE Field Diagnostics

Company Overview

Snapshot

Founded in February 2015 by Ofer Rahamim and Dr. David Shoseyov, NE Field Diagnostics operates with 1-10 employees. The company has raised $800,000 across one funding round from two investors, focusing on developing an innovative pulmonary function testing and monitoring device.

Business overview

NE Field Diagnostics specializes in developing and commercializing an innovative technology for lung function testing and monitoring. The company's core product, A-Spire, focuses on accurately measuring alveolar pressure to calculate airway resistance and respiratory compliance, which are critical parameters for diagnosing and monitoring pulmonary diseases. NE Field Diagnostics aims to provide a reliable solution for home monitoring of chronic respiratory conditions such as COPD and Asthma, serving both B2B and B2C markets in North America and China.

Company Intelligence Q&A

What is NE Field Diagnostics' primary focus?

NE Field Diagnostics focuses on developing and commercializing an innovative technology for lung function testing and monitoring, specifically designed to measure alveolar pressure for diagnosing and monitoring pulmonary diseases.

When was NE Field Diagnostics founded?

NE Field Diagnostics was founded in February 2015.

Who are the founders of NE Field Diagnostics?

NE Field Diagnostics was founded by Ofer Rahamim and Dr. David Shoseyov.

What is the total funding raised by NE Field Diagnostics?

NE Field Diagnostics has raised a total of $800,000 in a Pre-Seed round. This funding was secured in 2015 from two investors.

What markets does NE Field Diagnostics target?

NE Field Diagnostics targets geomarkets in North America and China, providing solutions for chronic respiratory diseases like COPD and Asthma.